Insulin Glargine vs Palivizumab

## Insulin Glargine vs Palivizumab: Overview

This comparison examines the pharmacological differences between **Insulin Glargine** and **Palivizumab**.

## Mechanism of Action

**Insulin Glargine**: Long-acting insulin analogue that binds insulin receptors.

## Pharmacokinetics

**Half-life**: Insulin Glargine — 12-24 hours; Palivizumab — N/A.

## Chemical Properties

**Type**: Insulin Glargine — Protein; Palivizumab — Antibody.